Inogen hopes new CEO can bring better results
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Clinicas del Camino Real opens new urgent care center in Simi
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen beats Q3 expectations, discusses Horizon purchase
Thousand Oaks-based Amgen has a lot on the horizon as it nears the end of fiscal year 2023, with the company yet again beating analysts’ expectations, this time in the third quarter, and beginning the onboarding process of its latest acquisition. Amgen delivered sales worth $6.9 billion in the third quarter of 2023, up 4% Read More →
SDRI, MannKind partner on inhaled insulin trial
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen completes $27.8B acquisition of Horizon
Thousand Oaks-based Amgen completed its largest acquisition in company history on Oct. 6, purchasing Horizon Therapeutics plc for $116.50 per share in cash, representing a transaction equity value of approximately $27.8 billion. “Today marks an exciting milestone as we welcome Horizon employees to Amgen and begin working together to serve even more patients around the world suffering from Read More →
Dubroff: Five ways the Sutter purchase will shake up Tri-County healthcare
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Santa Barbara firm partners with UCLA for new cancer treatments
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
